Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer.
This study has been completed.
Study NCT00432562 Information provided by Adventrx Pharmaceuticals
First Received: February 6, 2007 Last Updated: November 15, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Non-Small Cell Lung Cancer
Non-Hodgkins Lymphoma
Additional conditions recognized in this trial
Breast Neoplasms
Carcinoma, Non-Small-Cell Lung
Lung Neoplasms
Lymphoma
Lymphoma, Non-Hodgkin
More general conditions related to this trial
Breast Diseases
Carcinoma
Immune System Diseases
Immunoproliferative Disorders
Lung Diseases
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Skin Diseases
Thoracic Neoplasms
Interventions listed in this trial
Vinorelbine Tartrate
Additional drug interventions recognized in this trial
Vinblastine
Vinorelbine
More general drug interventions related to this trial
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
Adventrx Pharmaceuticals
Back to top of Main Content
